Advertisement #1
Home Cancer Risk

Cancer Risk

Cancer risk

Severe Oral Mucositis: Companies Put Their Money where the Mouth is and Vie for...

Bryan Oronsky, MD. Ph.D. -

Why are Patient Registries Key to Accelerating Rare Disease Research?

Padma Rammoorthy, MD -

Black and Hispanic Breast Cancer Survivors have Higher Mortality Rate After a Second Malignancy

Editorial Team -

Reducing Reliance on Blood Transfusions for People With Lower-risk Myelodysplastic Syndromes

Editorial Team -

Dostarlimab + Chemotherapy Accepted for dMMR/MSI-H Primary Advanced or Recurrent Endometrial Cancer

Editorial Team -

Radiation after Chemoimmunotherapy for Primary Mediastinal B-cell Lymphoma may Not be Necessary

Editorial Team -

Ciltacabtagene Autoleucel Reduces Risk of Progression of Multiple Myeloma after Lenalidomide

Editorial Team -

Trastuzumab Deruxtecan Is an Effective Option for Difficult-to-treat HER2-expressing Solid Tumors

Editorial Team -

Study Shows Nivolumab Reduces Risk of Disease Progression in Advanced, Untreated Hodgkin Lymphoma

Editorial Team -

Radiation Can Be Safely Omitted in Select Patients With Locally Advanced Rectal Cancer

Editorial Team -
123...28Page 1 of 28

LATEST NEWS

Advertisment #12
© 2001 - 2023 Sunvalley Communication, LLC. All Rights Reserved.

X